KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 130 filers reported holding KYMERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,299 | -38.9% | 5,057,425 | +1.0% | 0.01% | -37.5% |
| Q2 2023 | $115,115 | -16.7% | 5,007,148 | +7.3% | 0.02% | -23.8% |
| Q1 2023 | $138,275 | +26.5% | 4,666,681 | +6.6% | 0.02% | +16.7% |
| Q4 2022 | $109,303 | -99.9% | 4,379,159 | +6.9% | 0.02% | +20.0% |
| Q3 2022 | $89,208,000 | -13.3% | 4,097,712 | -21.6% | 0.02% | +15.4% |
| Q2 2022 | $102,874,000 | -37.6% | 5,224,686 | +34.1% | 0.01% | -23.5% |
| Q1 2022 | $164,845,000 | -26.9% | 3,895,205 | +9.7% | 0.02% | -15.0% |
| Q4 2021 | $225,423,000 | +18.7% | 3,550,528 | +9.8% | 0.02% | +11.1% |
| Q3 2021 | $189,918,000 | +112.2% | 3,233,197 | +75.2% | 0.02% | +125.0% |
| Q2 2021 | $89,479,000 | +146.8% | 1,844,926 | +97.7% | 0.01% | +100.0% |
| Q1 2021 | $36,256,000 | +49.1% | 932,978 | +138.0% | 0.00% | +100.0% |
| Q4 2020 | $24,309,000 | +155.3% | 392,076 | +33.0% | 0.00% | +100.0% |
| Q3 2020 | $9,522,000 | – | 294,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 639,059 | $37,538,000 | 24.22% |
| BVF INC/IL | 3,180,658 | $186,832,000 | 7.29% |
| Deer IX & Co. Ltd. | 615,895 | $36,178,000 | 3.72% |
| Asymmetry Capital Management, L.P. | 89,071 | $5,232,000 | 3.14% |
| Redmile Group, LLC | 2,793,708 | $164,102,000 | 2.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,260 | $21,103,000 | 1.77% |
| CLOUGH CAPITAL PARTNERS L P | 271,000 | $15,919,000 | 0.96% |
| Rock Springs Capital Management LP | 732,927 | $43,052,000 | 0.90% |
| Eagle Health Investments LP | 37,000 | $2,173,000 | 0.69% |
| Avidity Partners Management LP | 514,500 | $30,222,000 | 0.67% |